Premium
The N orwegian M ultiple S clerosis R egistry and B iobank
Author(s) -
Myhr K.M.,
Grytten N.,
Torkildsen Ø.,
Wergeland S.,
Bø L.,
Aarseth J. H.
Publication year - 2015
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.12427
Subject(s) - biobank , norwegian , medicine , multiple sclerosis , disease , disease registry , epidemiology , health care , medline , family medicine , bioinformatics , pathology , immunology , philosophy , linguistics , political science , economics , law , biology , economic growth
Multiple sclerosis ( MS ) is a chronic inflammatory disease of the central nervous system with unknown cause and various benefits from disease modifying therapies. Systematic recording of data into national MS registries is therefore needed to optimize treatment and define the pathogenesis of the disease. The Norwegian MS Registry and Biobank was established for systematic collection of clinical and epidemiological data, as well as biological samples. Data collection is based on informed consent from the individual patients and recordings by treating neurologists. All researchers have, by application, access to data and biological samples from the Norwegian Multiple Sclerosis Registry and Biobank. By this combined effort from both patients and healthcare personnel, the Registry and Biobank aims to facilitate research for improved understanding of disease mechanisms and improved health care in MS .